This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Eutilex Co., Ltd., National Cancer Center. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gyeonggi-do, KR (2018 - 2020)
- Seoul, KR (2022)
Company Filing History:
Years Active: 2018-2022
Title: Innovations by Kwang-Hui Kim in Cancer Treatment
Introduction
Kwang-Hui Kim, based in Gyeonggi-do, South Korea, is a prominent inventor with a focus on advancements in cancer research and treatment. With a total of five patents to his name, he has made significant contributions to the field, particularly in developing monoclonal antibodies and innovative cellular therapies aimed at combating B cell lymphoma and enhancing cancer treatment methodologies.
Latest Patents
Kwang-Hui Kim's latest inventions revolve around two groundbreaking patents. The first patent involves a monoclonal antibody that specifically targets B cell lymphoma cells. This invention is crucial as it provides a multifaceted approach to addressing B cell lymphoma through various applications, including a pharmaceutical composition for prevention or treatment, diagnostic methods, and the development of CAR-modified T cells that can specifically target cancer cells. The second patent focuses on a method for isolating and proliferating autologous cancer antigen-specific CD8T cells. This technique is notable for its ability to leverage a patient’s own T cells to recognize and eliminate cancer cells effectively, thus minimizing side effects typically associated with traditional cancer treatments.
Career Highlights
Kwang-Hui Kim has worked with notable organizations such as Eutilex Co., Ltd. and the National Cancer Center, where he has applied his research and inventions to real-world applications in oncology. His work not only emphasizes innovation but also reflects a commitment to enhancing patient outcomes through advanced therapeutic methods.
Collaborations
Throughout his career, Kwang-Hui Kim has collaborated with esteemed colleagues, including Byoung S. Kwon and Don-Gil Lee. These partnerships have facilitated significant research breakthroughs and the successful development of his inventions, fostering a collaborative environment that encourages innovation in cancer treatment.
Conclusion
Kwang-Hui Kim's contributions to cancer research through his patented innovations exemplify the critical role of inventors in the biomedical field. His work in developing targeted therapies represents a significant advancement in the treatment of B cell lymphoma, highlighting the importance of continued innovation in improving healthcare outcomes for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile